Endoverdi
ActiveEndoverdi has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €164k and a net result of €92k. Equity is growing by ~103.6% per year across the filed fiscal years. Its solvency ranks better than 82% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2024
90
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €14k at 30 days acceptable
Liquidity ample (current ratio 9.68 against 5.93 in 2023; short-term debt: 10.2% and cash: 21.4% of total assets), and 10.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
89.8%
Return on assets
50.1%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 08-07-2025, 23 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
not confirmed
2024
23 d early
2023
321 d late
2022
22 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€164k▲ 126%
2023 · €73k
2022: €14k
2023: €73k
2022 → 2024
Total assets
€183k▲ 110%
2023 · €87k
2022: €17k
2023: €87k
2022 → 2024
Net result
€92k▲ 56.2%
2023 · €59k
2022: €11k
2023: €59k
2022 → 2024
Working capital
€162k▲ 123%
2023 · €73k
2022: €14k
2023: €73k
2022 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202220232024Trend
Equity€14k-€73k▲ 423%€164k▲ 126%
Operating result€14k-€74k▲ 440%€114k▲ 54.5%
Net result€11k-€59k▲ 440%€92k▲ 56.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen two years in a row; 2024 is 55% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €183k
Fixed assets
€2k
Current assets
€181k
Equity and liabilities €183k
Equity
€164k▲ 126%
Debt
€19k▲ 26.7%
The debt ratio falls from 16.9% to 10.2%. Equity and debt are higher.
Key figures and ratios
EBITDA
€114k
Cash flow
€92k
Solvency
89.8%▲
2023 · 83.1%
Current ratio
9.68▲
2023 · 5.93
Quick ratio
9.68▲
2023 · 5.93
Debt / equity
0.11▼
2023 · 0.20
ROE
55.8%▼
2023 · 80.9%
ROA
50.1%▼
2023 · 67.2%
Interest coverage
1143.72
Debt
€19k▲
2023 · €15k
Debt ≤ 1 year
€19k▲
2023 · €15k
Income taxes
€24k▲
2023 · €15k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€87k€183k▲
Fixed assets21/28-€2k
Tangible fixed assets22/27-€2k
Furniture and vehicles24-€2k
Current assets29/58€87k€181k▲
Amounts receivable after more than one year29€26k€26k=
Other amounts receivable291€26k€26k=
Amounts receivable within one year40/41€1k€26k▲
Trade receivables40€906-
Other amounts receivable41€247€26k▲
Current investments50/53-€60k
Cash at bank and in hand54/58€60k€39k▼
Deferred charges and accrued income490/1€555€30k▲
Equity and liabilities
Total equity and liabilities10/49€87k€183k▲
Equity10/15€73k€164k▲
Contributions10/11€3k€3k=
Reserves13€70k€161k▲
Distributable reserves133€70k€161k▲
Amounts payable17/49€15k€19k▲
Amounts payable within one year42/48€15k€19k▲
Trade debts44€795€715▼
Suppliers440/4€795€715▼
Taxes, remuneration and social security45€13k€18k▲
Taxes450/3€13k€18k▲
Other amounts payable47/48€897-
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€394
Other operating charges640/8-€135
Gross operating margin9900€74k€115k▲
Operating profit (loss)9901€74k€114k▲
Financial income75/76B€233€2k▲
Recurring financial income75€233€2k▲
Financial charges65/66B-€100
Recurring financial charges65-€100
Profit (loss) for the period before taxes9903€74k€116k▲
Income taxes67/77€15k€24k▲
Profit (loss) for the period9904€59k€92k▲
Profit (loss) for the period to be appropriated9905€59k€92k▲
Appropriation of the result
Profit (loss) to be appropriated9906€59k€92k▲
Transfer to equity691/2€59k€92k▲
To other reserves6921€59k€92k▲
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
08-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
17-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 321 days late
2024
31-12
Financial
Highest result since 2022net €92k ▲56.2%
Operating result €114k, net result €92k, both a record.
31-12
Financial
Equity above €150kEq €164k ▲126%
3 profitable years in a row build equity to €164k.
2023
22-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 22 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schaarbeek · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Emile Maxlaan 1621030 SchaarbeekGround area
2,818 m²
Building footprint
516 m²
Volume, LiDAR
7,594 m³
2 parcels, Brussels, Flanders · tallest building 26.2 m, ±8 floors. Linked by address, not a title deed.
1 establishment unit
Endoverdi
since 20222.337.019.020
2 parcels
Flanders
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12005D0014/00G000 | Flanders | 1,804 m² | 1 · 258 m² | 9.4 m · 2 fl. |
| 21905C0095/00M009 | Brussels | 1,014 m² | 1 · 258 m² | 26.2 m · 8 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
LABNEST
BE 0788.689.380
Kortrijk · Eq €164k
Dokter Schrooten Leen
BE 0819.210.134
Beringen · Eq €164k
CLIDERM
BE 0644.732.670
Anderlecht · Eq €164k
Doctropicale
BE 0775.794.518
Zemst · Eq €164k
Dr. EVH, oogarts
BE 1001.121.360
Leuven · Eq €165k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,783 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded03-10-2022
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.